爱康国宾回应患癌女子体检漏查：报告曾提示“左肾错构瘤可能”，将请三方权威机构论证分析

Core Viewpoint - The incident involving a woman diagnosed with late-stage cancer after ten years of normal health check-ups raises significant concerns about the accuracy and reliability of health screening services provided by Aikang Group [1][3][4]. Company Response - Aikang Group stated that some cancers can be detected while others cannot, emphasizing that the health check reports accurately reflect the results at the time of examination [1][3]. - The company plans to engage third-party authoritative institutions and experts to analyze the reasons behind the undetected cancer cases, with the final conclusions based on their recommendations [1][3][5]. Health Screening Findings - The woman had normal cancer marker levels (carcinoembryonic antigen) throughout her ten years of check-ups at Aikang, with no alerts regarding cancer risks for her kidneys or spine [4][5]. - In 2024, after switching to a different health screening provider, a cyst measuring 3.5cm x 2.8cm was discovered in her right kidney, which was later diagnosed as renal cell carcinoma [4][5]. Industry Implications - The incident has sparked discussions within the health screening industry regarding the limitations of detection technologies and the varying levels of professional expertise among practitioners [6]. - It highlights the need for continuous updates in detection equipment and technology, as well as improved training and management for healthcare professionals [6]. Legal Considerations - Legal experts suggest that the key issue is whether Aikang Group fulfilled its diagnostic obligations according to the medical standards at the time of the examinations [7]. - If it is determined that necessary checks were not performed, it could lead to claims of misdiagnosis or missed diagnosis, potentially resulting in liability for Aikang Group [7].